Teprotumumab Phase III Trial Top Line Results Released

Horizon Pharma has just released top line results for the Phase III trial of Teprotumumab, a potential new treatment for thyroid eye disease. Detailed Phase III data will be submitted for publication in a peer-reviewed journal and presented at a medical congress later this year. Click this link to learn more: http://bit.ly/2ECfINj

Raymond Douglas, M.D., Ph.D., the study’s co-principal investigator, director of the orbital and thyroid eye disease program ...

Read More

Wendy Williams Video Greeting!

Talk show host Wendy Williams from The Wendy Williams Show recorded a special greeting to kick off the Graves' Disease & Thyroid Foundation's 2018 Patient & Family Conference in San Diego, CA!

On behalf of the GDATF's staff and Board - and all of our conference attendees - a million thanks to Wendy and her team for taking the time to let Graves' patients know that they are not alone!

Click here to watch the video!

Read More

Recent News

• Patient Education Event in Seattle on June 30th - Register Today!

  May 8, 2019, 9:05 a.m.

• Top Line Teprotumumab Phase III Trial Results Released

  March 1, 2019, 8:22 a.m.

• Registration Open for Los Angeles Patient Event!

  Feb. 22, 2019, 11:08 a.m.

• Los Angeles Patient Education Event!

  Feb. 6, 2019, 10:01 a.m.

• Holiday Schedule 2018-19

  Dec. 23, 2018, 8:56 a.m.